<--- Back to Details
First PageDocument Content
Thyroid neoplasm / Follicular thyroid cancer / Metastasis / Renal cell carcinoma / Thyroidectomy / Thyroid / Lung cancer / Oncology / Medullary thyroid cancer / Medicine / Thyroid cancer / Papillary thyroid cancer
Thyroid neoplasm
Follicular thyroid cancer
Metastasis
Renal cell carcinoma
Thyroidectomy
Thyroid
Lung cancer
Oncology
Medullary thyroid cancer
Medicine
Thyroid cancer
Papillary thyroid cancer

Add to Reading List

Source URL: jco.ascopubs.org

Download Document from Source Website

File Size: 649,60 KB

Share Document on Facebook

Similar Documents

POSTER SESSION 1: NEOPLASMS. VARIA. Exhibition area, 7 May, 09.00 – 12.00 h Chairperson: Radko Radev (Varna), Secretary: Vessela Uzunova (Sofia) 1. The therapy of the advanced renal cell carcinoma – new agents and st

POSTER SESSION 1: NEOPLASMS. VARIA. Exhibition area, 7 May, 09.00 – 12.00 h Chairperson: Radko Radev (Varna), Secretary: Vessela Uzunova (Sofia) 1. The therapy of the advanced renal cell carcinoma – new agents and st

DocID: 1uMwb - View Document

Assessment RunPAX8 Material The slide to be stained for PAX8 comprised: 1. Fallopian tube, 2. Tonsil, 3. Kidney, 4. Renal clear cell carcinoma,

Assessment RunPAX8 Material The slide to be stained for PAX8 comprised: 1. Fallopian tube, 2. Tonsil, 3. Kidney, 4. Renal clear cell carcinoma,

DocID: 1uiGA - View Document

· RENAL CELL CARCINOMA ·  Biomarkers for Renal Cell and Urothelial Carcinoma Nazli Dizman, MD, Joann Hsu, BS, Paulo Bergerot, MD, Manuel Caitano Maia, MD, and Sumanta K. Pal, MD  Keywords: Biomarkers, renal cell carcin

· RENAL CELL CARCINOMA · Biomarkers for Renal Cell and Urothelial Carcinoma Nazli Dizman, MD, Joann Hsu, BS, Paulo Bergerot, MD, Manuel Caitano Maia, MD, and Sumanta K. Pal, MD Keywords: Biomarkers, renal cell carcin

DocID: 1sTBk - View Document

www.edoriumjournals.com  CASE REPORT PEER REVIEWED | OPEN ACCESS

www.edoriumjournals.com CASE REPORT PEER REVIEWED | OPEN ACCESS

DocID: 1qNSk - View Document

sorafenib clinical trial risks of sorafenib sorafenib gastric cancer. sorafenib agent sorafenib pulmonary risks sorafenib lung cancer sorafenib dosage

sorafenib clinical trial risks of sorafenib sorafenib gastric cancer. sorafenib agent sorafenib pulmonary risks sorafenib lung cancer sorafenib dosage

DocID: 1qmZp - View Document